Impact of psychological stress on irritable bowel syndrome

World Journal of Gastroenterology

Volumn 20, Issue 39, 2014, Pages 14126-14131

  Qin, Hong Yan ^a,b   Cheng, Chung Wah ^b   Tang, Xu Dong ^c   Bian, Zhao Xiang ^b  

^a LANZHOU UNIVERSITY   (China)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Immune activation; Irritable bowel syndrome; Microbiota gut brain axis; Psychological stress

Indexed keywords

ABDOMINAL DISTENSION; ABDOMINAL PAIN; CENTRAL NERVOUS SYSTEM; CLINICAL RESEARCH; COGNITIVE THERAPY; COMORBIDITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISTRESS SYNDROME; DOCTOR PATIENT RELATION; EARLY LIFE STRESS; HUMAN; INTESTINE FLORA; INTESTINE INNERVATION; INTESTINE MOTILITY; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; MENTAL STRESS; NONHUMAN; PATHOGENESIS; PATIENT EDUCATION; REVIEW; ANIMAL; BRAIN; COMPLICATION; INNERVATION; INTESTINE; IRRITABLE BOWEL SYNDROME; PATHOPHYSIOLOGY; PROGNOSIS; PSYCHOLOGY; RISK FACTOR;

ANIMALS; BRAIN; HUMANS; INTESTINES; IRRITABLE BOWEL SYNDROME; PROGNOSIS; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 84910142952     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i39.14126     Document Type: Review

References (51)

1. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712-721.e4 [PMID: 22426087]
2. Drossman DA, Corazziari E, Delvaux M, Spiller RC, Talley NJ, Thompson WG, Whitehead WE, McLean V. Rome III: The functional gastrointestinal disorders. 3rd ed. Virginia: Degnon Associates, 2006
3. Katsanos AH, Giannopoulos S, Georgios Tsivgoulis. The braingut axis in the pathophysiology of irritable bowel syndrome. Immuno-Gastroenterol 2012; 1: 23-26 [DOI: 10.7178/ig.1.1.6]
4. Camilleri M, Di Lorenzo C. Brain-gut axis: from basic understanding to treatment of IBS and related disorders. J Pediatr Gastroenterol Nutr 2012; 54: 446-453 [PMID: 22027566 DOI: 10.1097/MPG.0b013e31823d34c3]
5. Sperber AD, Drossman DA. Irritable bowel syndrome: a multidimensional disorder cannot be understood or treated from a unidimensional perspective. Therap Adv Gastroenterol 2012; 5: 387-393 [PMID: 23152732 DOI: 10.1177/1756283X12460420]
6. Karantanos T, Markoutsaki T, Gazouli M, Anagnou NP, Karamanolis DG. Current insights in to the pathophysiology of Irritable Bowel Syndrome. Gut Pathog 2010; 2: 3 [PMID: 20465787 DOI: 10.1186/1757-4749-2-3]
7. Konturek PC, Brzozowski T, Konturek SJ. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol 2011; 62: 591-599 [PMID: 22314561]
8. Musial F, Häuser W, Langhorst J, Dobos G, Enck P. Psychophysiology of visceral pain in IBS and health. J Psychosom Res 2008; 64: 589-597 [PMID: 18501259 DOI: 10.1016/j.jpsychores.2008.02.024]
9. Larauche M, Mulak A, Taché Y. Stress and visceral pain: from animal models to clinical therapies. Exp Neurol 2012; 233: 49-67 [PMID: 21575632 DOI: 10.1016/j.expneurol.2011.04.020]
10. Larauche M, Mulak A, Taché Y. Stress-related alterations of visceral sensation: animal models for irritable bowel syndrome study. J Neurogastroenterol Motil 2011; 17: 213-234 [PMID: 21860814 DOI: 10.5056/jnm.2011.17.3.213]
11. Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and disease. Front Physiol 2011; 2: 94 [PMID: 22162969 DOI: 10.3389/fphys.2011.00094]
12. O'Malley D, Quigley EM, Dinan TG, Cryan JF. Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome? Brain Behav Immun 2011; 25: 1333-1341 [PMID: 21536124 DOI: 10.1016/j.bbi.2011.04.009]
13. Barbara G, Stanghellini V, Cremon C, De Giorgio R, Corinaldesi R. What is the effect of inflammation on intestinal function? Inflamm Bowel Dis 2008; 14 Suppl 2: S140-S144 [PMID: 18816685 DOI: 10.1002/ibd.20701]
14. Sturiale S, Barbara G, Qiu B, Figini M, Geppetti P, Gerard N, Gerard C, Grady EF, Bunnett NW, Collins SM. Neutral end opeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci USA 1999; 96: 11653-11658 [PMID: 10500232]
15. Bonfrate L, Tack J, Grattagliano I, Cuomo R, Portincasa P. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol 2013; 48: 995-1009 [PMID: 23964766 DOI: 10.3109/00365521.2013.799220]
16. Aguilera M, Vergara P, Martínez V. Stress and antibiotics alter luminal and wall-adhered microbiota and enhance the local expression of visceral sensory-related systems in mice. Neurogastroenterol Motil 2013; 25: e515-e529 [PMID: 23711047 DOI: 10.1111/nmo.12154]
17. Ringel Y, Maharshak N. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2013; 305: G529-G541 [PMID: 23886861 DOI: 10.1152/ajpgi.00207.2012]
18. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012; 13: 701-712 [PMID: 22968153 DOI: 10.1038/nrn3346]
19. Singh P, Agnihotri A, Pathak MK, Shirazi A, Tiwari RP, Sreenivas V, Sagar R, Makharia GK. Psychiatric, somatic and other functional gastrointestinal disorders in patients with irritable bowel syndrome at a tertiary care center. J Neurogastroenterol Motil 2012; 18: 324-331 [PMID: 22837881 DOI: 10.5056/jnm.2012.18.3.324]
20. Dekel R, Drossman DA, Sperber AD. The use of psychotropic drugs in irritable bowel syndrome. Expert Opin Investig Drugs 2013; 22: 329-339 [PMID: 23316916 DOI: 10.1517/13543784.2013.761205]
21. Surdea-Blaga T, Bəban A, Dumitrascu DL. Psychosocial determinants of irritable bowel syndrome. World J Gastroenterol 2012; 18: 616-626 [PMID: 22363132 DOI: 10.3748/wjg.v18.i7.616]
22. Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology 2011; 140: 761-765 [PMID: 21256129 DOI: 10.1053/j.gastro.2011.01.032]
23. Bradford K, Shih W, Videlock EJ, Presson AP, Naliboff BD, Mayer EA, Chang L. Association between early adverse life events and irritable bowel syndrome. Clin Gastroenterol Hepatol 2012; 10: 385-390.e1-3 [PMID: 22178460 DOI: 10.1016/j.cgh.2011.12.018]
24. Blanchard EB, Lackner JM, Jaccard J, Rowell D, Carosella AM, Powell C, Sanders K, Krasner S, Kuhn E. The role of stress in symptom exacerbation among IBS patients. J Psychosom Res 2008; 64: 119-128 [PMID: 18222125 DOI: 10.1016/j.jpsychores.2007.10.010]
25. Farzaneh N, Ghobakhlou M, Moghimi-Dehkordi B, Naderi N, Fadai F. Evaluation of psychological aspects among subtypes of irritable bowel syndrome. Indian J Psychol Med 2012; 34: 144-148 [PMID: 23162190 DOI: 10.4103/0253-7176.101780]
26. Barreau F, Salvador-Cartier C, Houdeau E, Bueno L, Fioramonti J. Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats. Gut 2008; 57: 582-590 [PMID: 18194988 DOI: 10.1136/gut.2007.126680]
27. Larauche M. Novel insights in the role of peripheral cortico-tropin-releasing factor and mast cells in stress-induced visceral hypersensitivity. Neurogastroenterol Motil 2012; 24: 201-205 [PMID: 22316289 DOI: 10.1111/j.1365-2982.2011.01867.x]
28. van den Wijngaard RM, Stanisor OI, van Diest SA, Welting O, Wouters MM, de Jonge WJ, Boeckxstaens GE. Peripheral α-helical CRF (9-41) does not reverse stress-induced mast cell dependent visceral hypersensitivity in maternally separated rats. Neurogastroenterol Motil 2012; 24: 274-282, e111 [PMID: 22129370 DOI: 10.1111/j.1365-2982.2011.01840.x]
29. Feng B, La JH, Schwartz ES, Gebhart GF. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2012; 302: G1085-G1098 [PMID: 22403791 DOI: 10.1152/ajpgi.00542.2011]
30. Bian ZX, Qin HY, Tian SL, Qi SD. Combined effect of early life stress and acute stress on colonic sensory and motor responses through serotonin pathways: differences between proximal and distal colon in rats. Stress 2011; 14: 448-458 [PMID: 21438781 DOI: 10.3109/10253890.2011.558604]
31. Bian ZX, Zhang M, Han QB, Xu HX, Sung JJ. Analgesic effects of JCM-16021 on neonatal maternal separation-induced visceral pain in rats. World J Gastroenterol 2010; 16: 837-845 [PMID: 20143462]
32. Ren TH, Wu J, Yew D, Ziea E, Lao L, Leung WK, Berman B, Hu PJ, Sung JJ. Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2007; 292: G849-G856 [PMID: 17110521 DOI: 10.1152/ajpgi.00400.2006]
33. Manocha M, Khan WI. Serotonin and GI Disorders: An Update on Clinical and Experimental Studies. Clin Transl Gastroenterol 2012; 3: e13 [PMID: 23238212 DOI: 10.1038/ctg.2012.8]
34. Spiller R. Serotonin and GI clinical disorders. Neuropharmacology 2008; 55: 1072-1080 [PMID: 18687345 DOI: 10.1016/j.neuropharm.2008.07.016]
35. Lambert GP. Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects. J Anim Sci 2009; 87: E101-E108 [PMID: 18791134 DOI: 10.2527/jas.2008-1339]
36. Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol 2010; 1: 97-105 [PMID: 21607147 DOI: 10.4291/wjgp.v1.i3.97]
37. Schmulson M, Chey WD. Abnormal immune regulation and low-grade inflammation in IBS: does one size fit all? Am J Gastroenterol 2012; 107: 273-275 [PMID: 22306945 DOI: 10.1038/ajg.2011.427]
38. Chung EK, Zhang XJ, Xu HX, Sung JJ, Bian ZX. Visceral hyperalgesia induced by neonatal maternal separation is associated with nerve growth factor-mediated central neuronal plasticity in rat spinal cord. Neuroscience 2007; 149: 685-695 [PMID: 17913374 DOI: 10.1016/j.neuroscience.2007.07.055]
39. Chung EK, Zhang X, Li Z, Zhang H, Xu H, Bian Z. Neonatal maternal separation enhances central sensitivity to noxious colorectal distention in rat. Brain Res 2007; 1153: 68-77 [PMID: 17434464 DOI: 10.1016/j.brainres.2007.03.047]
40. Bravo JA, Dinan TG, Cryan JF. Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders. Int J Neuropsychopharmacol 2011; 14: 666-683 [PMID: 20860876 DOI: 10.1017/S1461145710000994]
41. Luo JL, Qin HY, Wong CK, Tsang SY, Huang Y, Bian ZX. Enhanced excitability and down-regulated voltage-gated potassium channels in colonic drg neurons from neonatal maternal separation rats. J Pain 2011; 12: 600-609 [PMID: 21296029 DOI: 10.1016/j.jpain.2010.11.005]
42. Hu S, Xu W, Miao X, Gao Y, Zhu L, Zhou Y, Xiao Y, Xu GY. Sensitization of sodium channels by cystathionine β-synthetase activation in colon sensory neurons in adult rats with neonatal maternal deprivation. Exp Neurol 2013; 248: 275-285 [PMID: 23834820 DOI: 10.1016/j.expneurol.2013.06.027]
43. Amano H, Negishi I, Akiyama H, Ishikawa O. Psychological stress can trigger atopic dermatitis in NC/Nga mice: an inhibitory effect of corticotropin-releasing factor. Neuropsychopharmacology 2008; 33: 566-573 [PMID: 17460609 DOI: 10.1038/sj.npp.1301435]
44. Bradesi S, Schwetz I, Ennes HS, Lamy CM, Ohning G, Fanselow M, Pothoulakis C, McRoberts JA, Mayer EA. Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia. Am J Physiol Gastrointest Liver Physiol 2005; 289: G42-G53 [PMID: 15746211 DOI: 10.1152/ajpgi.00500.2004]
45. O'Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EM, Cryan JF, Dinan TG. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 2009; 65: 263-267 [PMID: 18723164 DOI: 10.1016/j.biopsych.2008.06.026]
46. Parkes GC, Brostoff J, Whelan K, Sanderson JD. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment. Am J Gastroenterol 2008; 103: 1557-1567 [PMID: 18513268 DOI: 10.1111/j.1572-0241.2008.01869.x]
47. Stasi C, Rosselli M, Bellini M, Laffi G, Milani S. Altered neuro-endocrine- immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. J Gastroenterol 2012; 47: 1177-1185 [PMID: 22766747 DOI: 10.1007/s00535-012-0627-7]
48. Halland M, Talley NJ. New treatments for IBS. Nat Rev Gastroenterol Hepatol 2013; 10: 13-23 [PMID: 23147658 DOI: 10.1038/nrgastro.2012.207]
49. Brown PM, Drossman DA, Wood AJ, Cline GA, Frazier KS, Jackson JI, Bronner J, Freiman J, Zambrowicz B, Sands A, Gershon MD. The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. Gastroenterology 2011; 141: 507-516 [PMID: 21684281 DOI: 10.1053/j.gastro.2011.05.005]
50. Gale JD. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation. Adv Ther 2009; 26: 519-530 [PMID: 19444393 DOI: 10.1007/s12325-009-0027-4]
51. Camilleri M. Review article: new receptor targets for medical therapy in irritable bowel syndrome. Aliment Pharmacol Ther 2010; 31: 35-46 [PMID: 19785622 DOI: 10.1111/j.1365-2036.2009.04153.x]